Novo CEO pressed by Senate to cut prices of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the company would look at new talks with insurers with regard to the record prices of Wegovy and copyright when they pledge to help keep the medicines on their formularies. https://arizona-hard-tea-nutritio07406.uzblog.net/the-2-minute-rule-for-healthcare-news-44707549